Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

TDRD1 Activators

The chemical class known as TDRD1 Activators encompasses a diverse range of compounds that can influence the activity of the Tudor Domain Containing 1 (TDRD1) protein. These activators do not directly interact with TDRD1; instead, they exert their influence through modulatory effects on various cellular pathways and processes that are connected to the functional expression and regulation of TDRD1. The action of these chemicals can lead to alterations in gene expression, modifications in chromatin structure, and changes in protein stability, each contributing to the regulation of TDRD1 activity. These compounds can inhibit or interfere with enzymes like DNA methyltransferases and histone demethylases, which are responsible for epigenetic modifications influencing gene expression patterns linked with TDRD1's role. Additionally, they can affect proteasome activity, leading to a shift in the degradation rate of proteins that associate with or regulate TDRD1.

Further, this class includes compounds that can disrupt signaling pathways such as those mediated by mTOR, PI3K, TGF-beta, and MEK. By doing so, they can induce cellular responses like autophagy or alter the phosphorylation state of proteins involved in signal transduction, ultimately affecting the cellular context within which TDRD1 operates. Moreover, some chemicals in this class can activate enzymes like AMPK, thereby influencing cellular energy homeostasis and metabolic pathways connected to TDRD1's biological functions. Through these varied mechanisms, the activators can modulate the cellular milieu to foster a state that supports the functional activity of TDRD1. It is through the convergence of these different biochemical routes that the members of this chemical class can have a composite effect on the regulation and activity of TDRD1 within cells.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Inhibits DNA methyltransferases, which could lead to demethylation of genes involved in the piRNA pathway, potentially affecting TDRD1 function by altering gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can induce autophagy and might affect TDRD1 by altering the turnover of cellular components involved in RNA metabolism.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Influences sirtuin activity and may affect the epigenetic regulation of genes involved in TDRD1-mediated processes.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase (HDAC) inhibitor that can alter chromatin structure and potentially upregulate genes necessary for TDRD1 function.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Another HDAC inhibitor that could have a similar effect to Trichostatin A on chromatin structure and gene expression affecting TDRD1.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that could alter cellular signaling pathways, potentially affecting TDRD1 activity.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

An inhibitor of the TGF-beta receptor that might modify signaling pathways that influence the cellular environment of TDRD1.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that could stabilize proteins associated with TDRD1 and modulate its functional interactions.